Jumlah Saham Beredar | 77,105,799 shares |
Saham Orang Dalam | 1,060,395 shares |
Kepemilikan oleh Orang Dalam | 1.38 % |
Orang Dalam Sejati | 38 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
-1 ( )
9883 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
5172 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Xenon Pharmaceuticals Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Sherry Aulin Chief Financial Officer - [O] | 0 | 0 | |
Ernesto Aycardi-fonseca Chief Medical Officer - [O] | 0 | 0 | |
Mohammad Azab Director - [D] | 74,225 | 74,225 | |
Biotechnology Value Fund Ii Lp - | 59,464 | 59,464 | |
Biotechnology Value Fund L P - | 59,464 | 59,464 | |
Bvf Inc/il
10% Owner -
|
59,464 | 59,464 | |
Bvf Partners L P/il
10% Owner -
|
59,464 | 59,464 | |
BVF Partners OS Ltd. - | 59,464 | 59,464 | |
Biotechnology Value Trading Fund OS LP - | 59,464 | 59,464 | |
Gary Bridger | 5,144 | ||
Cohen Charles J. VP, Biology - [O] | 6,550 | 6,550 | |
Corraini Karen G. See Remarks - [O] | 4,114 | 4,114 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Gillian Cannon Director - [D] | 0 | 0 | |
Darren S Cline Chief Commercial Officer - [O] | 0 | 0 | |
Clarissa Desjardins Director - [D] | 0 | 0 | |
Andrea DiFabio Chief Legal Officer - [O] | 0 | 0 | |
Empfield James R. EVP, Drug Discovery - [O] | 10,000 | 10,000 | |
Johnston L Evans Director - [D] | 444,655 | 444,655 | |
Steven Gannon Director - [D] | 7,141 | 7,141 | |
Garofalo Elizabeth A. Director - [D] | 0 | 0 | |
Goldberg Y. Paul VP of Clinical Development - [O] | 6,000 | 6,000 | |
Gover Justin D. Director - [D] | 0 | 0 | |
Frank A Holler Director - [D] | 143,653 | 143,653 | |
Michael R Hayden Director - [D] | 116,206 | 116,206 | |
Christopher John Kenney Chief Medical Officer - [O] | 0 | 0 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Mark N Lampert
10% Owner -
|
59,464 | 59,464 | |
Ian Mortimer PRESIDENT & CEO, Director - [D] [O] | 31,302 | 31,302 | |
Associates, LLP MX
10% Owner -
|
0 | 0 | |
Patrick Machado Director - [D] | 0 | 0 | |
Gary Patou Director - [D] | 23,573 | 23,573 | |
Pimstone Simon N. Director - [D] | 6,000 | 6,000 | |
Sherrington Robin EVP, Strategy & Innovation - [O] | 8,398 | 8,398 | |
Richard H Scheller Director - [D] | 7,000 | 7,000 | |
Stein Evan A. Director - [D] | 4,172 | 4,172 | |
Dawn Svoronos Director - [D] | 25,000 | 25,000 | |
Michael M Tarnow Director - [D] | 77,942 | 77,942 | |
Seggern Christopher Von Chief Commercial Officer - [O] | 4,000 | 4,000 | |
Raymond Winquist Head, Translational Research - [O] | 1,000 | 1,000 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di XENE / Xenon Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di XENE / Xenon Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-24 | 3 | Cline Darren S | XENE | No securities are beneficially owned. | D | 0 | ||||||||
2025-06-06 | 2025-06-05 | 4 | GANNON STEVEN | XENE | Common Shares | D | 30.4800 | -3 | -0 | 7,141 | ||||
2025-05-16 | 2025-05-14 | 4 | GANNON STEVEN | XENE | Common Shares | D | 12.5700 | 5,144 | 65 | 7,144 | ||||
2025-01-27 | 2025-01-27 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41.0700 | -1,149 | -47 | 31,302 | ||||
2025-01-27 | 2025-01-27 | 4 | MORTIMER IAN | XENE | Common Shares | D | 17.7600 | 1,149 | 20 | 32,451 | ||||
2025-01-27 | 2025-01-27 | 4 | MORTIMER IAN | XENE | Common Shares | D | 40.4600 | -15,166 | -614 | 31,302 | ||||
2025-01-27 | 2025-01-27 | 4 | MORTIMER IAN | XENE | Common Shares | D | 17.7600 | 15,166 | 269 | 46,468 | ||||
2025-01-27 | 2025-01-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 40.2000 | -22,468 | -903 | 31,302 | ||||
2025-01-27 | 2025-01-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 17.7600 | 22,468 | 399 | 53,770 | ||||
2025-01-27 | 2025-01-23 | 4 | MORTIMER IAN | XENE | Common Shares | D | 40.0800 | -16,217 | -650 | 31,302 | ||||
2025-01-27 | 2025-01-23 | 4 | MORTIMER IAN | XENE | Common Shares | D | 17.7600 | 16,217 | 288 | 47,519 | ||||
2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 41.1900 | -11,510 | -474 | 0 | ||||
2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 41.2800 | -4,490 | -185 | 11,510 | ||||
2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 11.5800 | 16,000 | 185 | 16,000 | ||||
2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 41.2300 | -7,199 | -297 | 0 | ||||
2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 41.2800 | -2,135 | -88 | 7,199 | ||||
2024-12-19 | 2024-12-18 | 4 | AULIN SHERRY | XENE | Common Shares | D | 9.4400 | 9,334 | 88 | 9,334 | ||||
2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 41.0500 | -2,040 | -84 | 23,573 | ||||
2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 39.8000 | -1,046 | -42 | 25,613 | ||||
2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 13.4800 | 3,086 | 42 | 26,659 | ||||
2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 41.1100 | -2,851 | -117 | 23,573 | ||||
2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 39.8000 | -649 | -26 | 26,424 | ||||
2024-11-22 | 2024-11-22 | 4 | PATOU GARY | XENE | Common Shares | D | 7.3800 | 3,500 | 26 | 27,073 | ||||
2024-03-11 | 2024-03-08 | 4 | GAROFALO ELIZABETH A. | XENE | Common Shares | D | 45.6900 | -2,092 | -96 | 0 | ||||
2024-03-11 | 2024-03-08 | 4 | GAROFALO ELIZABETH A. | XENE | Common Shares | D | 46.1600 | -1,408 | -65 | 2,092 | ||||
2024-03-11 | 2024-03-08 | 4 | GAROFALO ELIZABETH A. | XENE | Common Shares | D | 18.5600 | 3,500 | 65 | 3,500 | ||||
2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 46.3000 | -6,118 | -283 | 8,398 | ||||
2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 46.1500 | -1,019 | -47 | 14,516 | ||||
2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 45.9600 | -1,289 | -59 | 15,535 | ||||
2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 9.8500 | 7,407 | 73 | 16,824 | ||||
2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 45.9600 | -215 | -10 | 9,417 | ||||
2024-03-08 | 2024-03-07 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 9.8500 | 1,234 | 12 | 9,632 | ||||
2024-03-08 | 2024-03-07 | 4 | GANNON STEVEN | XENE | Common Shares | D | 46.2012 | -2,000 | -92 | 2,000 | ||||
2024-03-08 | 2024-03-07 | 4 | GANNON STEVEN | XENE | Common Shares | D | 46.3025 | -5,000 | -232 | 4,000 | ||||
2024-03-08 | 2024-03-07 | 4 | GANNON STEVEN | XENE | Common Shares | D | 46.2500 | -5,000 | -231 | 9,000 | ||||
2024-03-08 | 2024-03-07 | 4 | GANNON STEVEN | XENE | Common Shares | D | 46.4500 | -1,000 | -46 | 14,000 | ||||
2024-01-02 | 2023-12-29 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | -8,398 | 8,398 | ||||||
2023-12-20 | 2023-12-19 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 9.8500 | 3,497 | 34 | 74,225 | ||||
2023-12-20 | 2023-12-19 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 9.8500 | 823 | 8 | 70,728 | ||||
2023-12-15 | 2023-12-14 | 4/A | PATOU GARY See Note | XENE | Common Shares | I | 41.0500 | -7,598 | -312 | 4,902 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY See Note | XENE | Common Shares | I | 41.0500 | -7,598 | -312 | 4,902 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39.8400 | -3,977 | -158 | 23,573 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39.6800 | -1,167 | -46 | 27,550 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 9.0000 | 5,144 | 46 | 28,717 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39.1000 | -2,303 | -90 | 23,573 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39.6800 | -577 | -23 | 25,876 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 9.8500 | 2,880 | 28 | 26,453 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 38.9400 | -5,100 | -199 | 23,573 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 39.6800 | -1,278 | -51 | 28,673 | ||||
2023-12-15 | 2023-12-13 | 4 | PATOU GARY | XENE | Common Shares | D | 9.8500 | 6,378 | 63 | 29,951 | ||||
2023-08-24 | 2023-08-24 | 4 | Svoronos Dawn | XENE | Common Shares | D | 38.7000 | -25,000 | -968 | 25,000 | ||||
2023-08-10 | 3 | Gover Justin D. | XENE | No securities are beneficially owned. | D | 0 | ||||||||
2023-08-10 | 3 | Cannon Gillian | XENE | No securities are beneficially owned. | D | 0 | ||||||||
2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.7800 | -24,255 | -941 | 6,000 | ||||
2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.5300 | -20,745 | -799 | 30,255 | ||||
2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 17.7600 | 45,000 | 799 | 51,000 | ||||
2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.9700 | -7,458 | -291 | 6,000 | ||||
2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.5300 | -1,860 | -72 | 13,458 | ||||
2023-06-01 | 2023-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 7.6900 | 9,318 | 72 | 15,318 | ||||
2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.6900 | -26,856 | -1,039 | 6,000 | ||||
2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.3700 | -23,144 | -888 | 32,856 | ||||
2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 17.7600 | 50,000 | 888 | 56,000 | ||||
2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.8100 | -23,670 | -919 | 6,000 | ||||
2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.3700 | -6,165 | -237 | 29,670 | ||||
2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9.8500 | 29,835 | 294 | 35,835 | ||||
2023-06-01 | 2023-05-31 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.5300 | -12,000 | -462 | 6,000 | ||||
2023-06-01 | 2023-05-30 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 39.9000 | -19,000 | -758 | 18,000 | ||||
2023-06-01 | 2023-05-30 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.6300 | -18,006 | -696 | 37,000 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41.4900 | -1,407 | -58 | 31,302 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41.8400 | -1,171 | -49 | 32,709 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 9.8500 | 6,172 | 61 | 33,880 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41.3700 | -13,179 | -545 | 27,708 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41.8400 | -3,902 | -163 | 40,887 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 9.8500 | 20,576 | 203 | 44,789 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41.4400 | -17,069 | -707 | 24,213 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 41.8400 | -7,310 | -306 | 41,282 | ||||
2023-05-26 | 2023-05-24 | 4 | MORTIMER IAN | XENE | Common Shares | D | 9.4400 | 42,592 | 402 | 48,592 | ||||
2023-03-24 | 2023-03-24 | 4 | KENNEY CHRISTOPHER JOHN | XENE | Common Shares | D | 35.0100 | -700 | -25 | 0 | ||||
2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 36.9400 | -8,242 | -304 | 55,006 | ||||
2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37.1300 | -1,618 | -60 | 63,248 | ||||
2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 2.5900 | 30,864 | 80 | 64,866 | ||||
2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37.0100 | -10,990 | -407 | 34,002 | ||||
2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37.1300 | -2,160 | -80 | 44,992 | ||||
2023-03-09 | 2023-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 2.6800 | 41,152 | 110 | 47,152 | ||||
2022-12-13 | 2022-12-12 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2.6800 | 3,086 | 8 | 69,905 | ||||
2022-11-28 | 2022-11-25 | 4 | PATOU GARY | XENE | Common Shares | D | 34.7911 | -1,937 | -67 | 23,573 | ||||
2022-11-28 | 2022-11-25 | 4 | PATOU GARY | XENE | Common Shares | D | 34.3700 | -120 | -4 | 25,510 | ||||
2022-11-28 | 2022-11-25 | 4 | PATOU GARY | XENE | Common Shares | D | 2.6800 | 2,057 | 6 | 25,630 | ||||
2022-11-28 | 2022-11-23 | 4 | PATOU GARY | XENE | Common Shares | D | 34.3265 | -2,057 | -71 | 23,573 | ||||
2022-11-09 | 3 | DiFabio Andrea | XENE | No securities are beneficially owned. | D | 0 | ||||||||
2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 39.5700 | -15,355 | -608 | 0 | ||||
2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 39.5300 | -3,293 | -130 | 15,355 | ||||
2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 4.7500 | 6,511 | 31 | 18,648 | ||||
2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 3.1000 | 2,292 | 7 | 12,137 | ||||
2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 8.4000 | 813 | 7 | 9,845 | ||||
2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 7.4900 | 32 | 0 | 9,032 | ||||
2022-09-07 | 2022-09-02 | 4 | AULIN SHERRY | XENE | Common Shares | D | 9.4400 | 9,000 | 85 | 9,000 | ||||
2022-09-02 | 2022-09-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 38.8000 | -8,776 | -341 | 16,796 | ||||
2022-09-02 | 2022-09-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 38.0300 | -35,103 | -1,335 | 25,572 | ||||
2022-09-02 | 2022-09-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 38.8100 | -6,121 | -238 | 60,675 | ||||
2022-09-02 | 2022-09-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4.7500 | 50,000 | 238 | 66,796 | ||||
2022-09-02 | 2022-08-31 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 38.5700 | -21,352 | -824 | 16,796 | ||||
2022-09-02 | 2022-08-31 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 37.8600 | -1,572 | -60 | 38,148 | ||||
2022-09-02 | 2022-08-31 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4.7500 | 5,000 | 24 | 39,720 | ||||
2022-09-02 | 2022-08-31 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 2.6700 | 17,488 | 47 | 34,720 | ||||
2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 38.6800 | -21,875 | -846 | 10,000 | ||||
2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 38.0800 | -35,868 | -1,366 | 31,875 | ||||
2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 38.0200 | -7,257 | -276 | 67,743 | ||||
2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 4.7500 | 45,000 | 214 | 75,000 | ||||
2022-08-16 | 2022-08-12 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 3.1000 | 20,000 | 62 | 30,000 | ||||
2022-08-16 | 2022-08-16 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.8700 | -20,000 | -777 | 6,000 | ||||
2022-08-16 | 2022-08-16 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.2900 | -32,058 | -1,228 | 26,000 | ||||
2022-08-16 | 2022-08-15 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37.7600 | -33,942 | -1,282 | 58,058 | ||||
2022-08-16 | 2022-08-12 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 39.1500 | -1,000 | -39 | 92,000 | ||||
2022-08-16 | 2022-08-12 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 38.6000 | -47,000 | -1,814 | 93,000 | ||||
2022-08-16 | 2022-08-12 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 37.9100 | -43,135 | -1,635 | 140,000 | ||||
2022-03-14 | 2022-03-10 | 4 | Von Seggern Christopher | XENE | Stock Option (Right to Buy) | D | 30.01 | 100,000 | 100,000 | |||||
2022-03-14 | 2022-03-10 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 30.01 | 75,000 | 75,000 | |||||
2022-03-14 | 2022-03-10 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 30.01 | 25,000 | 25,000 | |||||
2022-03-14 | 2022-03-10 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 30.01 | 400,000 | 400,000 | |||||
2022-03-14 | 2022-03-10 | 4 | KENNEY CHRISTOPHER JOHN | XENE | Stock Option (Right to Buy) | D | 30.01 | 125,000 | 125,000 | |||||
2022-03-14 | 2022-03-10 | 4 | AULIN SHERRY | XENE | Stock Option (Right to Buy) | D | 30.01 | 125,000 | 125,000 | |||||
2022-03-14 | 2022-03-10 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 30.01 | 65,000 | 65,000 | |||||
2022-03-08 | 2022-03-08 | 4/A | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.8000 | -2,500 | -77 | 193,135 | ||||
2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.5000 | -2,500 | -76 | 183,135 | ||||
2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.5500 | -2,500 | -76 | 185,635 | ||||
2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.2000 | -2,500 | -76 | 188,135 | ||||
2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.1000 | -2,500 | -75 | 190,635 | ||||
2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.8000 | -2,500 | -10 | 193,135 | ||||
2022-03-08 | 2022-03-08 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.6000 | -2,051 | -63 | 195,635 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.67 | -20,576 | 0 | |||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.5500 | -2,500 | -76 | 197,686 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.5000 | -7,500 | -229 | 200,186 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.5200 | -2,500 | -76 | 207,686 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.4400 | -4,516 | -137 | 210,186 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.4500 | -4,516 | -138 | 214,702 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.4900 | -4,517 | -138 | 219,218 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.6000 | -5,037 | -154 | 223,735 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.2300 | -1,990 | -60 | 228,772 | ||||
2022-03-08 | 2022-03-07 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.6700 | 20,576 | 76 | 230,762 | ||||
2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.67 | -10,288 | 0 | |||||
2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.5600 | -4,793 | -146 | 210,186 | ||||
2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 30.6600 | -4,532 | -139 | 214,979 | ||||
2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 31.4200 | -963 | -30 | 219,511 | ||||
2022-03-08 | 2022-03-04 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.6700 | 10,288 | 38 | 220,474 | ||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.67 | -6,172 | 0 | |||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.67 | -1,234 | 0 | |||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 30.2300 | -5,000 | -151 | 17,232 | ||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 31.0500 | -5,000 | -155 | 22,232 | ||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 30.1500 | -5,000 | -151 | 27,232 | ||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 30.5600 | -6,710 | -205 | 32,232 | ||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3.6700 | 6,172 | 23 | 38,942 | ||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 31.4200 | -696 | -22 | 32,770 | ||||
2022-03-08 | 2022-03-04 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3.6700 | 1,234 | 5 | 33,466 | ||||
2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 6.76 | -40,000 | 0 | |||||
2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 8.40 | -2,500 | 0 | |||||
2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30.5400 | -31,048 | -948 | 10,000 | ||||
2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30.6200 | -1,805 | -55 | 41,048 | ||||
2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30.2300 | -8,952 | -271 | 42,853 | ||||
2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 6.7600 | 40,000 | 270 | 51,805 | ||||
2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30.2300 | -695 | -21 | 11,805 | ||||
2022-03-08 | 2022-03-07 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 8.4000 | 2,500 | 21 | 12,500 | ||||
2022-03-08 | 2022-03-04 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 8.40 | -25,000 | 0 | |||||
2022-03-08 | 2022-03-04 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 30.7900 | -18,315 | -564 | 10,000 | ||||
2022-03-08 | 2022-03-04 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 31.4200 | -6,685 | -210 | 28,315 | ||||
2022-03-08 | 2022-03-04 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 8.4000 | 25,000 | 210 | 35,000 | ||||
2022-01-21 | 2022-01-21 | 4 | KENNEY CHRISTOPHER JOHN | XENE | Common Shares | D | 28.8100 | 700 | 20 | 700 | ||||
2021-12-17 | 2021-12-15 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3.67 | -3,086 | 0 | |||||
2021-12-17 | 2021-12-15 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3.6700 | 3,086 | 11 | 66,819 | ||||
2021-12-10 | 2021-12-08 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3.67 | -2,057 | 0 | |||||
2021-12-10 | 2021-12-08 | 4 | PATOU GARY | XENE | Common Shares | D | 3.6700 | 2,057 | 8 | 25,630 | ||||
2021-12-07 | 2021-12-06 | 4 | Von Seggern Christopher | XENE | Common Shares | D | 24.4000 | 4,000 | 98 | 4,000 | ||||
2021-11-16 | 2021-11-15 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 31.3300 | -17,557 | -550 | 210,186 | ||||
2021-08-25 | 3 | KENNEY CHRISTOPHER JOHN | XENE | No securities are beneficially owned. | D | 0 | ||||||||
2021-08-25 | 2021-08-23 | 4 | KENNEY CHRISTOPHER JOHN | XENE | Stock Option (Right to Buy) | D | 16.64 | 150,000 | 150,000 | |||||
2021-06-04 | 2021-06-03 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 18.56 | 10,000 | 10,000 | |||||
2021-06-04 | 2021-03-17 | 4 | PATOU GARY See Note | XENE | Common Shares | I | 19.4900 | 100 | 2 | 100 | ||||
2021-06-03 | 2021-06-03 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 18.56 | 10,000 | 10,000 | |||||
2021-06-03 | 2021-06-03 | 4 | Machado Patrick | XENE | Stock Option (Right to Buy) | D | 18.56 | 10,000 | 10,000 | |||||
2021-06-03 | 2021-06-03 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 18.56 | 10,000 | 10,000 | |||||
2021-06-03 | 2021-06-03 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 18.56 | 10,000 | 10,000 | |||||
2021-06-03 | 2021-06-03 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 18.56 | 10,000 | 10,000 | |||||
2021-06-03 | 2021-06-03 | 4 | GAROFALO ELIZABETH A. | XENE | Stock Option (Right to Buy) | D | 18.56 | 20,000 | 20,000 | |||||
2021-06-03 | 3 | GAROFALO ELIZABETH A. | XENE | No securities are beneficially owned. | D | 0 | ||||||||
2021-06-03 | 2021-06-03 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 18.56 | 125,000 | 125,000 | |||||
2021-06-03 | 2021-06-03 | 4 | AULIN SHERRY | XENE | Stock Option (Right to Buy) | D | 18.56 | 100,000 | 100,000 | |||||
2021-06-03 | 3 | AULIN SHERRY | XENE | No securities are beneficially owned. | D | 0 | ||||||||
2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.85 | -13,374 | 0 | |||||
2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.76 | -12,345 | 0 | |||||
2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 18.8100 | -2,912 | -55 | 32,232 | ||||
2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 18.8100 | -3,155 | -59 | 35,144 | ||||
2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 18.9100 | -2,192 | -41 | 38,299 | ||||
2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3.8500 | 13,374 | 51 | 40,491 | ||||
2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 18.9100 | -2,024 | -38 | 27,117 | ||||
2021-06-01 | 2021-05-28 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3.7600 | 12,345 | 46 | 29,141 | ||||
2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3.76 | -36,008 | 0 | |||||
2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3.76 | -3,086 | 0 | |||||
2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 18.6800 | -8,485 | -158 | 143,653 | ||||
2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 18.6900 | -2,579 | -48 | 152,138 | ||||
2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 18.8800 | -5,911 | -112 | 154,717 | ||||
2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3.7600 | 36,008 | 135 | 160,628 | ||||
2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 18.8800 | -507 | -10 | 124,620 | ||||
2021-06-01 | 2021-05-27 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3.7600 | 3,086 | 12 | 125,127 | ||||
2021-05-26 | 2021-05-24 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.76 | -22,633 | 0 | |||||
2021-05-26 | 2021-05-24 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 19.1700 | -5,076 | -97 | 227,743 | ||||
2021-05-26 | 2021-05-24 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.7600 | 22,633 | 85 | 232,819 | ||||
2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.67 | -5,144 | 0 | |||||
2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.67 | -1,028 | 0 | |||||
2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.87 | -2,057 | 0 | |||||
2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.6700 | 5,144 | 19 | 77,942 | ||||
2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.6700 | 1,028 | 4 | 72,798 | ||||
2021-05-20 | 2021-05-18 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.8700 | 2,057 | 8 | 71,770 | ||||
2021-05-20 | 2021-05-18 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3.85 | -3,500 | 0 | |||||
2021-05-20 | 2021-05-18 | 4 | Hayden Michael R | XENE | Common Shares | D | 3.8500 | 3,500 | 13 | 116,206 | ||||
2021-03-15 | 2021-03-12 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 20.55 | 65,000 | 65,000 | |||||
2021-03-15 | 2021-03-12 | 4 | Von Seggern Christopher | XENE | Stock Option (Right to Buy) | D | 20.55 | 60,000 | 60,000 | |||||
2021-03-15 | 2021-03-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 20.55 | 65,000 | 65,000 | |||||
2021-03-15 | 2021-03-12 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 20.55 | 100,000 | 100,000 | |||||
2021-03-15 | 2021-03-12 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 20.55 | 225,000 | 225,000 | |||||
2021-02-18 | 2021-02-18 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 2.68 | -30,864 | 0 | |||||
2021-02-18 | 2021-02-18 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3.67 | -10,288 | 0 | |||||
2021-02-18 | 2021-02-18 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 2.6800 | 30,864 | 83 | 92,076 | ||||
2021-02-18 | 2021-02-18 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3.6700 | 10,288 | 38 | 61,212 | ||||
2021-02-18 | 2021-02-16 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 2.68 | -5,144 | 0 | |||||
2021-02-18 | 2021-02-16 | 4 | Hayden Michael R | XENE | Common Shares | D | 2.6800 | 5,144 | 14 | 112,706 | ||||
2020-12-15 | 2020-12-15 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3.76 | -3,086 | 0 | |||||
2020-12-15 | 2020-12-15 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3.7600 | 3,086 | 12 | 63,733 | ||||
2020-11-05 | 2020-11-05 | 4 | Machado Patrick | XENE | Stock Option (Right to Buy) | D | 11.85 | 20,000 | 20,000 | |||||
2020-11-05 | 3 | Machado Patrick | XENE | No securities are beneficially owned | D | 0 | ||||||||
2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.76 | -5,144 | 0 | |||||
2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.76 | -5,144 | 0 | |||||
2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -10,288 | 69,713 | ||||||
2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.7600 | 5,144 | 19 | 80,001 | ||||
2020-10-29 | 2020-10-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.7600 | 5,144 | 19 | 80,001 | ||||
2020-10-29 | 2020-10-28 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3.76 | -2,057 | 0 | |||||
2020-10-29 | 2020-10-28 | 4 | PATOU GARY | XENE | Common Shares | D | 3.7600 | 2,057 | 8 | 23,573 | ||||
2020-08-24 | 2020-08-20 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | -45,000 | 210,186 | ||||||
2020-08-17 | 2020-08-17 | 4 | Von Seggern Christopher | XENE | Stock Option (Right to Buy) | D | 11.27 | 100,000 | 100,000 | |||||
2020-08-17 | 3 | Von Seggern Christopher | XENE | No securities are beneficially owned. | D | 0 | ||||||||
2020-06-10 | 2020-06-09 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.52 | -5,144 | 0 | |||||
2020-06-10 | 2020-06-09 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.5200 | 5,144 | 18 | 69,713 | ||||
2020-06-02 | 2020-06-01 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 13.11 | 10,000 | 10,000 | |||||
2020-06-02 | 2020-06-01 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.56 | -8,230 | 0 | |||||
2020-06-02 | 2020-06-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 13.7000 | -1,630 | -22 | 16,796 | ||||
2020-06-02 | 2020-06-01 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3.5600 | 8,230 | 29 | 18,426 | ||||
2020-06-02 | 2020-06-01 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 14.4300 | -3,000 | -43 | 255,186 | ||||
2020-06-02 | 2020-05-29 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 13.9900 | -5,000 | -70 | 258,186 | ||||
2020-06-02 | 2020-06-01 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 13.11 | 10,000 | 10,000 | |||||
2020-06-02 | 2020-05-29 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3.56 | -3,086 | 0 | |||||
2020-06-02 | 2020-05-29 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3.5600 | 3,086 | 11 | 122,041 | ||||
2020-06-02 | 2020-06-01 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 13.11 | 10,000 | 10,000 | |||||
2020-06-02 | 2020-06-01 | 4 | Desjardins Clarissa | XENE | Stock Option (Right to Buy) | D | 13.11 | 10,000 | 10,000 | |||||
2020-06-02 | 2020-06-01 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 13.11 | 10,000 | 10,000 | |||||
2020-06-02 | 2020-06-01 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 13.11 | 10,000 | 10,000 | |||||
2020-06-02 | 2020-06-01 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 13.11 | 10,000 | 10,000 | |||||
2020-06-02 | 2020-06-01 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 13.11 | 10,000 | 10,000 | |||||
2020-05-28 | 2020-05-26 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.56 | -6,172 | 0 | |||||
2020-05-28 | 2020-05-26 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 14.9000 | -1,108 | -17 | 263,186 | ||||
2020-05-28 | 2020-05-26 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.5600 | 6,172 | 22 | 264,294 | ||||
2020-03-13 | 2020-03-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 11.58 | 65,000 | 65,000 | |||||
2020-03-13 | 2020-03-12 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 11.58 | 65,000 | 65,000 | |||||
2020-03-13 | 2020-03-12 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 11.58 | 145,000 | 145,000 | |||||
2020-03-13 | 2020-03-12 | 4 | AYCARDI-FONSECA ERNESTO | XENE | Stock Option (Right to Buy) | D | 11.58 | 65,000 | 65,000 | |||||
2020-03-13 | 2020-03-12 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 11.58 | 280,000 | 280,000 | |||||
2020-01-14 | 2020-01-13 | 4 | Desjardins Clarissa | XENE | Stock Option (Right to Buy) | D | 16.42 | 25,000 | 25,000 | |||||
2020-01-14 | 3 | Desjardins Clarissa | XENE | No securities are beneficially owned | D | 0 | ||||||||
2019-12-17 | 2019-12-16 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3.56 | -3,086 | 0 | |||||
2019-12-17 | 2019-12-16 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3.5600 | 3,086 | 11 | 60,647 | ||||
2019-12-06 | 2019-12-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3.56 | -2,057 | 0 | |||||
2019-12-06 | 2019-12-04 | 4 | PATOU GARY | XENE | Common Shares | D | 3.5600 | 2,057 | 7 | 21,516 | ||||
2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.51 | -2,057 | 0 | |||||
2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.56 | -5,144 | 0 | |||||
2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -2,057 | 64,569 | ||||||
2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.5100 | 2,057 | 7 | 66,626 | ||||
2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -5,144 | 64,569 | ||||||
2019-11-22 | 2019-11-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.5600 | 5,144 | 18 | 69,713 | ||||
2019-09-24 | 2019-09-20 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9.5100 | -10,395 | -99 | 258,122 | ||||
2019-09-20 | 2019-09-20 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9.3900 | -5,206 | -49 | 118,955 | ||||
2019-09-20 | 2019-09-19 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9.2700 | -7,600 | -70 | 124,161 | ||||
2019-09-18 | 2019-09-16 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 9.44 | 15,000 | 15,000 | |||||
2019-09-18 | 2019-09-16 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 9.44 | 15,000 | 15,000 | |||||
2019-09-18 | 2019-09-16 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 9.44 | 45,000 | 45,000 | |||||
2019-09-18 | 2019-09-16 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 9.44 | 15,000 | 15,000 | |||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.38 | -12,345 | 0 | |||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.07 | -9,259 | 0 | |||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.70 | -36,008 | 0 | |||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9.4400 | -3,692 | -35 | 268,517 | ||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.3800 | 12,345 | 42 | 272,209 | ||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9.4400 | -2,769 | -26 | 259,864 | ||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.0700 | 9,259 | 28 | 262,633 | ||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 9.4400 | -10,769 | -102 | 253,374 | ||||
2019-09-18 | 2019-09-17 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.7000 | 36,008 | 133 | 264,143 | ||||
2019-09-18 | 2019-09-16 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 9.44 | 280,000 | 280,000 | |||||
2019-09-18 | 2019-09-18 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9.2800 | -4,368 | -41 | 131,761 | ||||
2019-09-18 | 2019-09-17 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9.3200 | -5,069 | -47 | 136,129 | ||||
2019-09-18 | 2019-09-16 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 9.44 | 15,000 | 15,000 | |||||
2019-09-18 | 2019-09-16 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 9.44 | 135,000 | 135,000 | |||||
2019-09-18 | 2019-09-16 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 9.44 | 15,000 | 15,000 | |||||
2019-09-18 | 2019-09-16 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 9.44 | 40,000 | 40,000 | |||||
2019-09-18 | 2019-09-16 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 9.44 | 15,000 | 15,000 | |||||
2019-09-18 | 2019-09-16 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 9.44 | 15,000 | 15,000 | |||||
2019-09-18 | 2019-09-16 | 4 | AYCARDI-FONSECA ERNESTO | XENE | Stock Option (Right to Buy) | D | 9.44 | 65,000 | 65,000 | |||||
2019-09-17 | 2019-09-16 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 9.44 | 15,000 | 15,000 | |||||
2019-09-17 | 2019-09-13 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 9.3122 | -23 | -0 | 57,561 | ||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3.00 | -25,720 | 0 | |||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3.07 | -3,086 | 0 | |||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3.70 | -3,086 | 0 | |||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9.3800 | -7,781 | -73 | 141,198 | ||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3.0000 | 25,720 | 77 | 148,979 | ||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9.3800 | -934 | -9 | 123,259 | ||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9.3800 | -934 | -9 | 123,259 | ||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3.0700 | 3,086 | 9 | 124,193 | ||||
2019-09-13 | 2019-09-12 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3.7000 | 3,086 | 11 | 122,041 | ||||
2019-09-13 | 2019-09-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.07 | -6,172 | 0 | |||||
2019-09-13 | 2019-09-12 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 9.3800 | -1,868 | -18 | 10,196 | ||||
2019-09-13 | 2019-09-12 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3.0700 | 6,172 | 19 | 12,064 | ||||
2019-05-23 | 2019-05-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.21 | -2,057 | 0 | |||||
2019-05-23 | 2019-05-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.2100 | 2,057 | 7 | 64,569 | ||||
2019-03-20 | 2019-03-19 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3.38 | -20,576 | 0 | |||||
2019-03-20 | 2019-03-19 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3.3800 | 20,576 | 70 | 50,924 | ||||
2019-03-12 | 2019-03-11 | 4 | Hayden Michael R By Spouse | XENE | Common Shares | I | 17,337 | 114,403 | ||||||
2019-03-12 | 2019-03-11 | 4 | Hayden Michael R | XENE | Common Shares | D | -24,045 | 107,562 | ||||||
2018-12-26 | 2018-12-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -5,000 | 62,512 | ||||||
2018-12-18 | 2018-12-14 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3.07 | -2,057 | 0 | |||||
2018-12-18 | 2018-12-14 | 4 | PATOU GARY | XENE | Common Shares | D | 3.0700 | 2,057 | 6 | 19,459 | ||||
2018-12-13 | 2018-12-11 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 3.07 | -4,115 | 0 | |||||
2018-12-13 | 2018-12-11 | 4 | COHEN CHARLES J. | XENE | Common Shares | D | 7.0000 | -1,644 | -12 | 6,550 | ||||
2018-12-13 | 2018-12-11 | 4 | COHEN CHARLES J. | XENE | Common Shares | D | 3.0700 | 4,115 | 13 | 8,194 | ||||
2018-12-10 | 2018-12-06 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3.07 | -3,086 | 0 | |||||
2018-12-10 | 2018-12-06 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3.0700 | 3,086 | 9 | 57,584 | ||||
2018-06-22 | 2018-06-21 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3.70 | -10,288 | 0 | |||||
2018-06-22 | 2018-06-21 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3.7000 | 10,288 | 38 | 54,498 | ||||
2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.07 | -5,144 | 0 | |||||
2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.70 | -5,144 | 0 | |||||
2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.66 | -2,057 | 0 | |||||
2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.0700 | 5,144 | 16 | 67,512 | ||||
2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.6600 | 2,057 | 8 | 62,368 | ||||
2018-06-22 | 2018-06-21 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.7000 | 5,144 | 19 | 60,311 | ||||
2018-06-15 | 2018-06-14 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3.70 | -8,230 | 0 | |||||
2018-06-15 | 2018-06-14 | 4 | PATOU GARY | XENE | Common Shares | D | 8.3000 | -2,856 | -24 | 17,402 | ||||
2018-06-15 | 2018-06-14 | 4 | PATOU GARY | XENE | Common Shares | D | 3.7000 | 8,230 | 30 | 20,258 | ||||
2018-06-05 | 2018-06-04 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 6.20 | 15,000 | 15,000 | |||||
2018-06-05 | 2018-06-04 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 6.20 | 15,000 | 15,000 | |||||
2018-06-05 | 2018-06-04 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 6.20 | 15,000 | 15,000 | |||||
2018-06-05 | 2018-06-04 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 6.20 | 15,000 | 15,000 | |||||
2018-06-05 | 2018-06-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 6.20 | 15,000 | 15,000 | |||||
2018-06-05 | 2018-06-04 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 6.20 | 15,000 | 15,000 | |||||
2018-06-05 | 2018-06-04 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 6.20 | 15,000 | 15,000 | |||||
2018-06-05 | 2018-06-04 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 6.20 | 15,000 | 15,000 | |||||
2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Series 1 Preferred Shares | D | 238,000 | 238,000 | ||||||
2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Series 1 Preferred Shares | D | 861,000 | 861,000 | ||||||
2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Series 1 Preferred Shares | D | 1,338,000 | 1,338,000 | ||||||
2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Shares, no par value per share | D | -238,000 | 59,464 | ||||||
2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Shares, no par value per share | D | -861,000 | 216,694 | ||||||
2018-03-29 | 2018-03-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Shares, no par value per share | D | -1,338,000 | 336,468 | ||||||
2018-03-20 | 3 | AYCARDI-FONSECA ERNESTO | XENE | No securities are beneficially owned | D | 0 | ||||||||
2018-03-20 | 2018-03-19 | 4 | AYCARDI-FONSECA ERNESTO | XENE | Stock Option (Right to Buy) | D | 4.65 | 50,000 | 50,000 | |||||
2018-03-16 | 2018-03-14 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3.77 | -3,086 | 0 | |||||
2018-03-16 | 2018-03-14 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 3.7700 | 3,086 | 12 | 118,955 | ||||
2018-03-16 | 2018-03-15 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.77 | -3,086 | 0 | |||||
2018-03-16 | 2018-03-15 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4.6250 | -1,928 | -9 | 5,892 | ||||
2018-03-16 | 2018-03-15 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3.7700 | 3,086 | 12 | 7,820 | ||||
2018-03-14 | 2018-03-12 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.77 | -10,288 | 0 | |||||
2018-03-14 | 2018-03-12 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.7700 | 10,288 | 39 | 228,135 | ||||
2018-03-13 | 2018-03-12 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 4.75 | 140,000 | 140,000 | |||||
2018-03-13 | 2018-03-12 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 4.75 | 105,000 | 105,000 | |||||
2018-03-13 | 2018-03-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 4.75 | 55,000 | 55,000 | |||||
2018-03-13 | 2018-03-12 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 4.75 | 45,000 | 45,000 | |||||
2018-03-13 | 2018-03-12 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 4.75 | 40,000 | 40,000 | |||||
2018-03-01 | 2018-02-22 | 4 | Hayden Michael R By Spouse | XENE | Common Shares | I | 21,180 | 97,066 | ||||||
2018-03-01 | 2018-02-22 | 4 | Hayden Michael R | XENE | Common Shares | D | -29,580 | 131,607 | ||||||
2018-02-14 | 2018-02-12 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 3.71 | -26,748 | 0 | |||||
2018-02-14 | 2018-02-12 | 4 | COHEN CHARLES J. | XENE | Common Shares | D | 3.5000 | -22,669 | -79 | 4,079 | ||||
2018-02-14 | 2018-02-12 | 4 | COHEN CHARLES J. | XENE | Common Shares | D | 3.7100 | 26,748 | 99 | 26,748 | ||||
2017-11-16 | 2017-11-15 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2.2187 | 15,000 | 33 | 44,210 | ||||
2017-10-24 | 2017-10-23 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 3.10 | 11,000 | 11,000 | |||||
2017-10-24 | 2017-10-23 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 3.10 | 20,000 | 20,000 | |||||
2017-10-24 | 2017-10-23 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3.10 | 11,000 | 11,000 | |||||
2017-10-24 | 2017-10-23 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.10 | 11,000 | 11,000 | |||||
2017-10-24 | 2017-10-23 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.10 | 11,000 | 11,000 | |||||
2017-10-24 | 2017-10-23 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 3.10 | 25,000 | 25,000 | |||||
2017-09-25 | 2017-09-22 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2.9500 | 8,000 | 24 | 29,210 | ||||
2017-09-25 | 2017-09-21 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2.9500 | 2,000 | 6 | 21,210 | ||||
2017-08-21 | 2017-08-18 | 4 | WINQUIST RAYMOND | XENE | Common Shares | D | 2.9950 | 1,000 | 3 | 1,000 | ||||
2017-08-21 | 2017-08-18 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2.8995 | 6,312 | 18 | 19,210 | ||||
2017-08-21 | 2017-08-17 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 2.6500 | 23 | 0 | 12,898 | ||||
2017-08-17 | 2017-08-15 | 4 | EMPFIELD JAMES R. | XENE | Common Shares | D | 2.4824 | 10,000 | 25 | 10,000 | ||||
2017-08-16 | 2017-08-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 2.4122 | 7,429 | 18 | 1,077,694 | ||||
2017-08-16 | 2017-08-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 2.4122 | 11,429 | 28 | 1,674,468 | ||||
2017-08-16 | 2017-08-14 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 2.7036 | 13,337 | 36 | 1,070,265 | ||||
2017-08-16 | 2017-08-14 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 2.7036 | 28,007 | 76 | 1,663,039 | ||||
2017-08-15 | 2017-08-14 | 4 | Svoronos Dawn | XENE | Common Shares | D | 2.8154 | 50,000 | 141 | 50,000 | ||||
2017-08-14 | 2017-08-11 | 4 | GANNON STEVEN | XENE | Common Shares | D | 2.8178 | 15,000 | 42 | 15,000 | ||||
2017-08-14 | 2017-08-14 | 4 | Hayden Michael R | XENE | Common Shares | D | 2.7498 | 15,000 | 41 | 161,187 | ||||
2017-08-14 | 2017-08-10 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 2.9000 | 6,000 | 17 | 217,847 | ||||
2017-08-14 | 2017-08-10 | 4 | SCHELLER RICHARD H | XENE | Common Shares | D | 2.8500 | 7,000 | 20 | 7,000 | ||||
2017-08-14 | 2017-08-10 | 4 | MORTIMER IAN By Spouse | XENE | Common Stock | I | 2.9000 | 10,000 | 29 | 14,300 | ||||
2017-08-14 | 2017-08-10 | 4 | MORTIMER IAN | XENE | Common Stock | D | 2.8450 | 5,000 | 14 | 6,000 | ||||
2017-08-14 | 2017-08-10 | 4 | PATOU GARY See Note | XENE | Common Stock | I | 2.7781 | 7,500 | 21 | 12,500 | ||||
2017-08-10 | 2017-08-08 | 4 | PATOU GARY See note | XENE | Common Stock | I | 3.0005 | 5,000 | 15 | 5,000 | ||||
2017-06-30 | 2017-06-27 | 4/A | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.0361 | 8,496 | 26 | 297,464 | ||||
2017-06-30 | 2017-06-27 | 4/A | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.0361 | 30,170 | 92 | 1,056,928 | ||||
2017-06-30 | 2017-06-27 | 4/A | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.0361 | 46,795 | 142 | 1,635,032 | ||||
2017-06-29 | 2017-06-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 8,496 | 34 | 297,464 | ||||
2017-06-29 | 2017-06-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 30,170 | 121 | 1,056,928 | ||||
2017-06-29 | 2017-06-27 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 46,795 | 187 | 1,635,032 | ||||
2017-06-23 | 2017-06-22 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 854 | 3 | 288,968 | ||||
2017-06-23 | 2017-06-22 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 2,884 | 12 | 1,026,758 | ||||
2017-06-23 | 2017-06-22 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 4,525 | 18 | 1,588,237 | ||||
2017-06-23 | 2017-06-21 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 1,362 | 5 | 288,114 | ||||
2017-06-23 | 2017-06-21 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 4,406 | 18 | 1,023,874 | ||||
2017-06-23 | 2017-06-21 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 4.0000 | 6,380 | 26 | 1,583,712 | ||||
2017-06-20 | 2017-06-19 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.51 | -1,028 | 0 | |||||
2017-06-20 | 2017-06-19 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -1,028 | 55,167 | ||||||
2017-06-20 | 2017-06-19 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.5100 | 1,028 | 4 | 56,195 | ||||
2017-06-19 | 2017-06-19 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8500 | 357 | 1 | 286,752 | ||||
2017-06-19 | 2017-06-19 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8500 | 1,271 | 5 | 1,019,468 | ||||
2017-06-19 | 2017-06-19 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8500 | 1,967 | 8 | 1,577,332 | ||||
2017-06-19 | 2017-06-16 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8500 | 1,064 | 4 | 286,395 | ||||
2017-06-19 | 2017-06-16 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8500 | 3,873 | 15 | 1,018,197 | ||||
2017-06-19 | 2017-06-16 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8500 | 6,097 | 23 | 1,575,365 | ||||
2017-06-19 | 2017-06-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8370 | 1,160 | 4 | 285,331 | ||||
2017-06-19 | 2017-06-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8370 | 3,845 | 15 | 1,014,324 | ||||
2017-06-19 | 2017-06-15 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8370 | 6,774 | 26 | 1,569,268 | ||||
2017-06-08 | 2017-06-07 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8512 | 20,594 | 79 | 284,171 | ||||
2017-06-08 | 2017-06-07 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8512 | 73,749 | 284 | 1,010,479 | ||||
2017-06-08 | 2017-06-07 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.8512 | 113,446 | 437 | 1,562,494 | ||||
2017-06-08 | 2017-06-06 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.7500 | 913 | 3 | 263,577 | ||||
2017-06-08 | 2017-06-06 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.7500 | 53,260 | 200 | 936,730 | ||||
2017-06-08 | 2017-06-06 | 4 | BVF PARTNERS L P/IL | XENE | Common Stock, no par value per share | D | 3.7500 | 96,736 | 363 | 1,449,048 | ||||
2017-06-02 | 2017-06-01 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 3.85 | 3,500 | 3,500 | |||||
2017-06-02 | 2017-06-01 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3.85 | 3,500 | 3,500 | |||||
2017-06-02 | 2017-06-01 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 3.85 | 3,500 | 3,500 | |||||
2017-06-02 | 2017-06-01 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3.85 | 3,500 | 3,500 | |||||
2017-06-02 | 2017-06-01 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3.85 | 3,500 | 3,500 | |||||
2017-06-02 | 2017-06-01 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.85 | 1,250 | 1,250 | |||||
2017-06-02 | 2017-06-01 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.85 | 3,500 | 3,500 | |||||
2017-06-02 | 2017-06-01 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 3.85 | 3,500 | 3,500 | |||||
2017-06-02 | 2017-06-01 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 3.85 | 3,500 | 3,500 | |||||
2017-05-16 | 2017-05-12 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 3.21 | -2,057 | 0 | |||||
2017-05-16 | 2017-05-12 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4.1800 | -1,345 | -6 | 4,734 | ||||
2017-05-16 | 2017-05-12 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 3.2100 | 2,057 | 7 | 6,079 | ||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3.56 | -3,086 | 0 | |||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3.07 | -4,629 | 0 | |||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3.77 | -4,115 | 0 | |||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3.67 | -5,144 | 0 | |||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3.76 | -25,720 | 0 | |||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 3.70 | -18,004 | 0 | |||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3.5600 | 3,086 | 11 | 30,348 | ||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3.0700 | 4,629 | 14 | 27,262 | ||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3.7700 | 4,115 | 16 | 22,633 | ||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Common Shares | D | 3.6700 | 5,144 | 19 | 146,187 | ||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Common Shares | D | 3.7600 | 25,720 | 97 | 141,043 | ||||
2017-03-15 | 2017-03-14 | 4 | Hayden Michael R | XENE | Common Shares | D | 3.7000 | 18,004 | 67 | 115,323 | ||||
2017-03-14 | 2017-03-13 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 8.40 | 75,000 | 75,000 | |||||
2017-03-14 | 2017-03-13 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 8.40 | 140,000 | 140,000 | |||||
2017-03-14 | 2017-03-13 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 8.40 | 27,500 | 27,500 | |||||
2017-03-14 | 2017-03-13 | 4 | WINQUIST RAYMOND | XENE | Stock Option (Right to Buy) | D | 8.40 | 20,000 | 20,000 | |||||
2017-03-14 | 2017-03-13 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 8.40 | 20,000 | 20,000 | |||||
2017-03-14 | 2017-03-13 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 8.40 | 27,500 | 27,500 | |||||
2017-03-14 | 2017-03-13 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 8.40 | 27,500 | 27,500 | |||||
2017-01-27 | 2017-01-26 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -7,201 | 55,167 | ||||||
2016-12-19 | 2016-12-15 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 7.8500 | -30,000 | -236 | 115,869 | ||||
2016-12-13 | 2016-12-12 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.21 | -14,403 | 0 | |||||
2016-12-13 | 2016-12-12 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -7,202 | 62,368 | ||||||
2016-12-13 | 2016-12-12 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.2100 | 14,403 | 46 | 69,570 | ||||
2016-12-08 | 2016-12-06 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 3.21 | -12,345 | 0 | |||||
2016-12-08 | 2016-12-06 | 4 | PATOU GARY | XENE | Common Shares | D | 7.9000 | -4,403 | -35 | 12,028 | ||||
2016-12-08 | 2016-12-06 | 4 | PATOU GARY | XENE | Common Shares | D | 3.2100 | 12,345 | 40 | 16,431 | ||||
2016-12-02 | 2016-12-01 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 3.21 | -12,345 | 0 | |||||
2016-12-02 | 2016-12-01 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 7.8000 | -4,408 | -34 | 12,875 | ||||
2016-12-02 | 2016-12-01 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 3.2100 | 12,345 | 40 | 17,283 | ||||
2016-09-27 | 3 | Svoronos Dawn | XENE | No securities are beneficially owned | D | 0 | ||||||||
2016-09-27 | 2016-09-27 | 4 | Svoronos Dawn | XENE | Stock Option (Right to Buy) | D | 8.15 | 5,144 | 5,144 | |||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,381,916 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2,761,110 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2,761,110 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,381,916 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,850,758 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2,761,110 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,381,916 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,850,758 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2,761,110 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,381,916 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,850,758 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2,761,110 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,381,916 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,850,758 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2,761,110 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,381,916 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,850,758 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2,761,110 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,381,916 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,850,758 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,850,758 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,381,916 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 3,850,758 | ||||||||
2016-09-12 | 3 | LAMPERT MARK N | XENE | Common Stock, no par value per share | D | 2,761,110 | ||||||||
2016-08-23 | 2016-08-19 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 7.6510 | -11,938 | -91 | 145,869 | ||||
2016-08-18 | 2016-08-18 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 7.7000 | -9,599 | -74 | 157,807 | ||||
2016-08-18 | 2016-08-17 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 7.8900 | -1,600 | -13 | 167,406 | ||||
2016-08-18 | 2016-08-16 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 8.2500 | -6,863 | -57 | 169,006 | ||||
2016-08-02 | 2016-07-29 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 3.30 | -12,345 | 0 | |||||
2016-08-02 | 2016-07-29 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 7.4600 | -4,703 | -35 | 211,847 | ||||
2016-08-02 | 2016-07-29 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 3.3000 | 12,345 | 41 | 216,550 | ||||
2016-06-28 | 2016-06-24 | 4 | MORTIMER IAN By spouse | XENE | Common Stock | I | 6.3000 | 1,300 | 8 | 4,300 | ||||
2016-06-28 | 2016-06-24 | 4 | MORTIMER IAN By spouse | XENE | Common Stock | I | 6.2500 | 2,000 | 12 | 3,000 | ||||
2016-06-28 | 2016-06-24 | 4 | MORTIMER IAN By spouse | XENE | Common Stock | I | 6.1000 | 1,000 | 6 | 1,000 | ||||
2016-06-28 | 2016-06-24 | 4 | MORTIMER IAN | XENE | Common Stock | D | 6.1500 | 1,000 | 6 | 1,000 | ||||
2016-06-03 | 2016-06-02 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 7.38 | 3,500 | 3,500 | |||||
2016-06-03 | 2016-06-02 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 7.38 | 3,500 | 3,500 | |||||
2016-06-03 | 2016-06-02 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 7.38 | 3,500 | 3,500 | |||||
2016-06-03 | 2016-06-02 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 7.38 | 3,500 | 3,500 | |||||
2016-06-03 | 2016-06-02 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 7.38 | 1,250 | 1,250 | |||||
2016-06-03 | 2016-06-02 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 7.38 | 3,500 | 3,500 | |||||
2016-06-03 | 2016-06-02 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 7.38 | 3,500 | 3,500 | |||||
2016-06-03 | 2016-06-02 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 7.38 | 3,500 | 3,500 | |||||
2016-05-27 | 2016-05-25 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 3.30 | -8,230 | 0 | |||||
2016-05-27 | 2016-05-25 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 3.3000 | 8,230 | 27 | 18,518 | ||||
2016-04-29 | 2016-04-28 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 3.35 | -1,543 | 0 | |||||
2016-04-29 | 2016-04-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -1,543 | 55,167 | ||||||
2016-04-29 | 2016-04-28 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 3.3500 | 1,543 | 5 | 56,710 | ||||
2016-04-04 | 3 | WINQUIST RAYMOND | XENE | No securities are beneficially owned | D | 0 | ||||||||
2016-04-04 | 2016-04-04 | 4 | WINQUIST RAYMOND | XENE | Stock Option (Right to Buy) | D | 7.10 | 35,000 | 35,000 | |||||
2016-03-11 | 2016-03-11 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 7.49 | 20,000 | 20,000 | |||||
2016-03-11 | 2016-03-11 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 7.49 | 40,000 | 40,000 | |||||
2016-03-11 | 2016-03-11 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 7.49 | 20,000 | 20,000 | |||||
2016-03-11 | 2016-03-11 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 7.49 | 25,000 | 25,000 | |||||
2016-03-11 | 2016-03-11 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 7.49 | 50,000 | 50,000 | |||||
2016-02-09 | 3 | EMPFIELD JAMES R. | XENE | No securities are beneficially owned | D | 0 | ||||||||
2016-02-09 | 2016-02-08 | 4 | EMPFIELD JAMES R. | XENE | Stock Option (Right to Buy) | D | 6.76 | 40,000 | 40,000 | |||||
2015-12-21 | 2015-12-18 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 7.69 | 15,000 | 15,000 | |||||
2015-12-21 | 2015-12-16 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 5.22 | -411 | 0 | |||||
2015-12-21 | 2015-12-16 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 7.9400 | -229 | -2 | 4,022 | ||||
2015-12-21 | 2015-12-16 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 5.2200 | 411 | 2 | 4,251 | ||||
2015-12-21 | 2015-12-18 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 7.69 | 40,000 | 40,000 | |||||
2015-12-21 | 2015-12-18 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 7.69 | 25,000 | 25,000 | |||||
2015-12-21 | 2015-12-18 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 7.69 | 15,000 | 15,000 | |||||
2015-12-21 | 2015-12-18 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 7.69 | 15,000 | 15,000 | |||||
2015-12-14 | 2015-12-11 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 5.22 | 2,469 | 0 | |||||
2015-12-14 | 2015-12-11 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 5.2200 | 2,469 | 13 | 4,938 | ||||
2015-11-25 | 2015-11-24 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 5.22 | -2,057 | 0 | |||||
2015-11-25 | 2015-11-24 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 9.3900 | -995 | -9 | 175,869 | ||||
2015-11-25 | 2015-11-24 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 5.2200 | 2,057 | 11 | 176,864 | ||||
2015-11-06 | 2015-11-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 5.22 | -3,497 | 0 | |||||
2015-11-06 | 2015-11-04 | 4 | PATOU GARY | XENE | Common Shares | D | 8.3200 | -1,955 | -16 | 4,086 | ||||
2015-11-06 | 2015-11-04 | 4 | PATOU GARY | XENE | Common Shares | D | 5.2200 | 3,497 | 18 | 6,041 | ||||
2015-11-04 | 2015-11-02 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 5.22 | -5,041 | 0 | |||||
2015-11-04 | 2015-11-02 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | -5,041 | 55,167 | ||||||
2015-11-04 | 2015-11-02 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 5.2200 | 5,041 | 26 | 60,208 | ||||
2015-09-24 | 2015-09-24 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 8.6000 | -12,000 | -103 | 6,000 | ||||
2015-09-24 | 2015-09-23 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.0200 | -4,000 | -36 | 18,000 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 2.68 | -785 | 243 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 2.68 | -7,973 | 4,372 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3.73 | -3,115 | 1,000 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3.52 | -3,703 | 0 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3.56 | -6,172 | 0 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3.07 | -5,144 | 0 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3.77 | -1,028 | 0 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 3.21 | -2,057 | 0 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 5.22 | -411 | 0 | |||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.3323 | -6,149 | -57 | 22,000 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -167 | -2 | 28,149 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 2.6800 | 785 | 2 | 28,316 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -1,687 | -16 | 27,531 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 2.6800 | 7,973 | 21 | 29,218 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -923 | -9 | 21,245 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3.7300 | 3,115 | 12 | 22,168 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -1,098 | -10 | 19,053 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3.5200 | 3,703 | 13 | 20,151 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -1,829 | -17 | 16,448 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3.5600 | 6,172 | 22 | 18,277 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -1,525 | -15 | 12,105 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3.0700 | 5,144 | 16 | 13,630 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -305 | -3 | 8,486 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3.7700 | 1,028 | 4 | 8,791 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -610 | -6 | 7,763 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 3.2100 | 2,057 | 7 | 8,373 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 9.5300 | -198 | -2 | 6,316 | ||||
2015-09-24 | 2015-09-22 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 5.2200 | 411 | 2 | 6,514 | ||||
2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 4.98 | -2,057 | ||||||
2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 4.81 | -1,028 | ||||||
2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 11.0000 | -868 | -10 | 3,840 | ||||
2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4.9800 | 2,057 | 10 | 4,708 | ||||
2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 11.0000 | -434 | -5 | 2,651 | ||||
2015-08-20 | 2015-08-18 | 4 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4.8100 | 1,028 | 5 | 3,085 | ||||
2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 4.98 | -15,432 | 0 | |||||
2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 4.81 | -5,144 | 0 | |||||
2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 11.0000 | -6,508 | -72 | 204,205 | ||||
2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 4.9800 | 15,432 | 77 | 210,713 | ||||
2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 11.0000 | -2,170 | -24 | 195,281 | ||||
2015-08-20 | 2015-08-18 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 4.8100 | 5,144 | 25 | 197,451 | ||||
2015-08-20 | 2015-08-18 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 4.98 | -2,057 | 0 | |||||
2015-08-20 | 2015-08-18 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 11.0000 | -868 | -10 | 174,807 | ||||
2015-08-20 | 2015-08-18 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 4.9800 | 2,057 | 10 | 175,675 | ||||
2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 4.98 | -2,057 | 0 | |||||
2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 4.81 | -1,028 | 0 | |||||
2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 11.0000 | -868 | -10 | 6,103 | ||||
2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 4.9800 | 2,057 | 10 | 6,971 | ||||
2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 11.0000 | -434 | -5 | 4,914 | ||||
2015-08-20 | 2015-08-18 | 4 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 4.8100 | 1,028 | 5 | 5,348 | ||||
2015-06-19 | 2015-06-17 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 4.95 | -1,543 | 0 | |||||
2015-06-19 | 2015-06-17 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 4.9500 | 1,543 | 8 | 55,167 | ||||
2015-05-22 | 3 | GANNON STEVEN | XENE | No securities are beneficially owned | D | 0 | ||||||||
2015-05-22 | 2015-05-21 | 4 | GANNON STEVEN | XENE | Stock Option (Right to Buy) | D | 12.57 | 5,144 | 5,144 | |||||
2015-05-06 | 2015-05-04 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 13.48 | 3,086 | 3,086 | |||||
2015-05-06 | 2015-05-04 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 13.48 | 3,086 | 3,086 | |||||
2015-05-06 | 2015-05-04 | 4 | Evans Johnston L | XENE | Stock Option (Right to Buy) | D | 13.48 | 3,086 | 3,086 | |||||
2015-05-06 | 2015-05-04 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 13.48 | 3,086 | 3,086 | |||||
2015-05-06 | 2015-05-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 13.48 | 3,086 | 3,086 | |||||
2015-05-06 | 2015-05-04 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 13.48 | 1,028 | 1,028 | |||||
2015-05-06 | 2015-05-04 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 13.48 | 3,086 | 3,086 | |||||
2015-05-06 | 2015-05-04 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 13.48 | 3,086 | 3,086 | |||||
2015-05-04 | 2015-04-30 | 4 | STEIN EVAN A. | XENE | Common Shares | I | 4,172 | 4,172 | ||||||
2015-05-04 | 2015-04-30 | 4 | STEIN EVAN A. | XENE | Common Shares | I | 909,619 | 910,586 | ||||||
2015-05-04 | 2015-04-30 | 4 | STEIN EVAN A. | XENE | Common Shares | I | -1,038,964 | 0 | ||||||
2015-03-19 | 2015-03-17 | 4 | ROBIN SHERRINGTON | XENE | Stock Option (Right to Buy) | D | 17.76 | 35,000 | 35,000 | |||||
2015-03-19 | 2015-03-17 | 4 | PIMSTONE SIMON N. | XENE | Stock Option (Right to Buy) | D | 17.76 | 95,000 | 95,000 | |||||
2015-03-19 | 2015-03-17 | 4 | MORTIMER IAN | XENE | Stock Option (Right to Buy) | D | 17.76 | 55,000 | 55,000 | |||||
2015-03-19 | 2015-03-17 | 4 | GOLDBERG Y. PAUL | XENE | Stock Option (Right to Buy) | D | 17.76 | 35,000 | 35,000 | |||||
2015-03-19 | 2015-03-17 | 4 | CORRAINI KAREN G. | XENE | Stock Option (Right to Buy) | D | 17.76 | 35,000 | 35,000 | |||||
2015-03-19 | 2015-03-17 | 4 | COHEN CHARLES J. | XENE | Stock Option (Right to Buy) | D | 17.76 | 35,000 | 35,000 | |||||
2015-03-18 | 3 | SCHELLER RICHARD H | XENE | No securities are beneficially owned | D | 0 | ||||||||
2015-03-18 | 2015-03-16 | 4 | SCHELLER RICHARD H | XENE | Stock Option (Right to Buy) | D | 17.65 | 5,144 | 5,144 | |||||
2015-02-05 | 2015-02-03 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 4.81 | -5,144 | 0 | |||||
2015-02-05 | 2015-02-03 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 4.8100 | 5,144 | 25 | 10,288 | ||||
2015-01-21 | 2015-01-07 | 4/A | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 4.98 | -3,497 | 0 | |||||
2015-01-21 | 2015-01-07 | 4/A | PATOU GARY | XENE | Common Shares | D | 22.2800 | -953 | -21 | 2,544 | ||||
2015-01-21 | 2015-01-07 | 4/A | PATOU GARY | XENE | Common Shares | D | 4.9800 | 3,497 | 17 | 3,497 | ||||
2015-01-12 | 2015-01-08 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 4.98 | -2,469 | 0 | |||||
2015-01-12 | 2015-01-08 | 4 | AZAB MOHAMMAD | XENE | Common Shares | D | 4.9800 | 2,469 | 12 | 2,469 | ||||
2015-01-12 | 2015-01-08 | 4 | Hayden Michael R By Genworks Inc. | XENE | Stock Option (Right to Buy) | I | 4.98 | -5,144 | 0 | |||||
2015-01-12 | 2015-01-08 | 4 | Hayden Michael R By Genworks Inc. | XENE | Common Shares | I | 4.9800 | 5,144 | 26 | 5,144 | ||||
2015-01-12 | 2015-01-08 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 4.98 | -5,041 | 0 | |||||
2015-01-12 | 2015-01-08 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 4.9800 | 5,041 | 25 | 53,624 | ||||
2015-01-09 | 2015-01-07 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 4.98 | -3,497 | 0 | |||||
2015-01-09 | 2015-01-07 | 4 | PATOU GARY | XENE | Common Shares | D | 4.9800 | 3,497 | 17 | 3,497 | ||||
2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | -17,680 | 0 | ||||||
2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | -85,119 | 17,680 | ||||||
2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | -85,119 | 17,680 | ||||||
2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | -117,456 | 187,918 | ||||||
2015-01-07 | 2014-12-31 | 4 | MX Associates, LLP | XENE | Common Shares | D | -1,169,286 | 305,374 | ||||||
2014-11-25 | 2014-11-21 | 4 | Bridger Gary | XENE | Stock Option (Right to Buy) | D | 12.65 | 5,144 | 5,144 | |||||
2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Series E Preferred Shares | D | -2,737 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Series B Preferred Shares | D | -4,988 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A By wife | XENE | Series A Preferred Shares | I | -941 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Series A Preferred Shares | D | -95,002 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A By wife | XENE | Common Shares | I | 941 | 1,184 | ||||||
2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 2,737 | 173,618 | ||||||
2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 4,988 | 170,881 | ||||||
2014-11-12 | 2014-11-09 | 4 | HOLLER FRANK A | XENE | Common Shares | D | 95,002 | 165,893 | ||||||
2014-11-12 | 2014-11-09 | 4 | Evans Johnston L By Invesco Capital Entities | XENE | Series E Preferred Shares | I | -444,655 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | Evans Johnston L By Invesco Capital Entities | XENE | Common Shares | I | 444,655 | 444,655 | ||||||
2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Series E Preferred Shares | I | -1,504 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Series B Preferred Shares | I | -2,693 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Series A Preferred Shares | I | -10,030 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Common Shares | I | 1,504 | 75,886 | ||||||
2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Common Shares | I | 2,693 | 74,382 | ||||||
2014-11-12 | 2014-11-09 | 4 | Hayden Michael R By wife | XENE | Common Shares | I | 10,030 | 71,689 | ||||||
2014-11-12 | 2014-11-09 | 4 | TARNOW MICHAEL M | XENE | Series A Preferred Shares | D | -16,718 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | TARNOW MICHAEL M | XENE | Common Shares | D | 16,718 | 48,583 | ||||||
2014-11-12 | 2014-11-09 | 4 | PIMSTONE SIMON N. | XENE | Series B Preferred Shares | D | -1,914 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | PIMSTONE SIMON N. | XENE | Series A Preferred Shares | D | -964 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 1,914 | 192,307 | ||||||
2014-11-12 | 2014-11-09 | 4 | PIMSTONE SIMON N. | XENE | Common Shares | D | 964 | 190,393 | ||||||
2014-11-12 | 2014-11-09 | 4 | STEIN EVAN A. By Lipoterx, Ltd. | XENE | Series E Preferred Shares | I | -1,038,964 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | STEIN EVAN A. By Stein Family LLC | XENE | Series B Preferred Shares | I | -967 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | STEIN EVAN A. By Lipoterx, Ltd. | XENE | Common Shares | I | 1,038,964 | 1,038,964 | ||||||
2014-11-12 | 2014-11-09 | 4 | STEIN EVAN A. By Stein Family LLC | XENE | Common Shares | I | 967 | 967 | ||||||
2014-11-12 | 2014-11-09 | 4 | MX Associates, LLP | XENE | Series E Preferred Shares | D | -1,474,660 | 0 | ||||||
2014-11-12 | 2014-11-09 | 4 | MX Associates, LLP | XENE | Common Shares | D | 1,474,660 | 1,474,660 | ||||||
2014-11-06 | 3/A | HOLLER FRANK A By wife | XENE | Common Shares | I | 243 | ||||||||
2014-11-06 | 3/A | HOLLER FRANK A | XENE | Common Shares | D | 70,891 | ||||||||
2014-11-06 | 2014-11-04 | 4 | TARNOW MICHAEL M | XENE | Stock Option (Right to Buy) | D | 9.00 | 5,144 | 5,144 | |||||
2014-11-06 | 2014-11-04 | 4 | Hayden Michael R | XENE | Stock Option (Right to Buy) | D | 9.00 | 5,144 | 5,144 | |||||
2014-11-06 | 2014-11-04 | 4 | AZAB MOHAMMAD | XENE | Stock Option (Right to Buy) | D | 9.00 | 5,144 | 5,144 | |||||
2014-11-06 | 2014-11-04 | 4 | Evans Johnston L | XENE | Stock Option (Right to Buy) | D | 9.00 | 5,144 | 5,144 | |||||
2014-11-06 | 2014-11-04 | 4 | PATOU GARY | XENE | Stock Option (Right to Buy) | D | 9.00 | 5,144 | 5,144 | |||||
2014-11-06 | 2014-11-04 | 4 | STEIN EVAN A. | XENE | Stock Option (Right to Buy | D | 9.00 | 5,144 | 5,144 | |||||
2014-11-06 | 2014-11-04 | 4 | HOLLER FRANK A | XENE | Stock Option (Right to Buy) | D | 9.00 | 5,144 | 5,144 | |||||
2014-11-04 | 3 | CORRAINI KAREN G. | XENE | Common Shares | D | 4,114 | ||||||||
2014-11-04 | 3 | CORRAINI KAREN G. | XENE | Common Shares | D | 4,114 | ||||||||
2014-11-04 | 3 | Hayden Michael R | XENE | Common Shares | D | 256,297 | ||||||||
2014-11-04 | 3 | Hayden Michael R By wife | XENE | Common Shares | I | 220,637 | ||||||||
2014-11-04 | 3 | Hayden Michael R | XENE | Common Shares | D | 256,297 | ||||||||
2014-11-04 | 3 | Hayden Michael R By wife | XENE | Common Shares | I | 220,637 | ||||||||
2014-11-04 | 3 | TARNOW MICHAEL M | XENE | Common Shares | D | 63,730 | ||||||||
2014-11-04 | 3 | TARNOW MICHAEL M | XENE | Common Shares | D | 63,730 | ||||||||
2014-11-04 | 3 | HOLLER FRANK A | XENE | Common Shares | D | 142,025 | ||||||||
2014-11-04 | 3 | HOLLER FRANK A By wife | XENE | Common Stock | I | 71,377 | ||||||||
2014-11-04 | 3 | HOLLER FRANK A | XENE | Common Shares | D | 142,025 | ||||||||
2014-11-04 | 3 | HOLLER FRANK A By wife | XENE | Common Stock | I | 71,377 | ||||||||
2014-11-04 | 3 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4,114 | ||||||||
2014-11-04 | 3 | ROBIN SHERRINGTON | XENE | Common Shares | D | 4,114 | ||||||||
2014-11-04 | 3 | PIMSTONE SIMON N. | XENE | Common Shares | D | 395,318 | ||||||||
2014-11-04 | 3 | PIMSTONE SIMON N. | XENE | Common Shares | D | 395,318 | ||||||||
2014-11-04 | 3 | PIMSTONE SIMON N. By wife | XENE | Common Shares | I | 222,349 | ||||||||
2014-11-04 | 3 | PIMSTONE SIMON N. By wife | XENE | Common Shares | I | 222,349 | ||||||||
2014-11-04 | 3 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 8,640 | ||||||||
2014-11-04 | 3 | GOLDBERG Y. PAUL | XENE | Common Shares | D | 8,640 |